Compare · ACCD vs DFPH
ACCD vs DFPH
Side-by-side comparison of Accolade Inc. (ACCD) and DFP Healthcare Acquisitions Corp. (DFPH): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while DFPH operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 3.7x DFPH ($315.7M).
- ACCD has more recent analyst coverage (25 ratings vs 0 for DFPH).
- Company
- Accolade Inc.
- DFP Healthcare Acquisitions Corp.
- Price
- $7.03+0.00%
- $10.90+8.46%
- Market cap
- $1.18B
- $315.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
DFP Healthcare Acquisitions Corp.
DFP Healthcare Acquisitions Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2019 and is based in New York, New York.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest DFPH
- DFP Healthcare Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (Amendment)
- SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.
- SEC Form 3: New insider M33 Growth I L.P. claimed ownership of 15,256,383 shares
- SEC Form 3: New insider Havencrest Healthcare Partners, L.P. claimed ownership of 15,662,794 shares
- SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.
- SEC Form SC 13D filed by DFP Healthcare Acquisitions Corp.
- SEC Form 4: Sarin Ravi Yang was granted 4,109,771 shares (Amendment)
- SEC Form SC 13D/A filed by DFP Healthcare Acquisitions Corp. (Amendment)
- SEC Form 4: Barasch Richard A bought $10,115 worth of shares (1,000 units at $10.12), increasing direct ownership by 1% to 86,113 units
- SEC Form 4: Hively Brad was granted 353,450 shares (Amendment)